Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

SUMO-1 protease-1 regulates gene transcription through PML.

Molecular cell | Oct 6, 2002

http://www.ncbi.nlm.nih.gov/pubmed/12419228

During a screen to identify c-Jun activators, we isolated a cysteine protease, SuPr-1, that induced c-Jun-dependent transcription independently of c-Jun phosphorylation. SuPr-1 is a member of a new family of proteases that hydrolyze the ubiquitin-like modifier, SUMO-1. SuPr-1 hydrolyzed SUMO-1-modified forms of the promyelocytic leukemia gene product, PML, and altered the subcellular distribution of PML in nuclear PODs (PML oncogenic domains). SuPr-1 also altered the distribution of other nuclear POD-associated proteins, such as CBP and Daxx, that act as transcriptional regulators. SuPr-1 action on transcription was enhanced by PML, and SuPr-1 failed to activate transcription in PML-deficient fibroblasts. Our studies establish an important role for SUMO proteases in transcription.

Pubmed ID: 12419228 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Base Sequence | Cell Line | Cell Nucleus Structures | Cysteine Endopeptidases | HeLa Cells | Humans | Mice | Molecular Sequence Data | Mutation | Neoplasm Proteins | Nuclear Proteins | Phosphorylation | Promoter Regions, Genetic | Protein Binding | Proto-Oncogene Proteins c-jun | Sequence Homology, Nucleic Acid | Substrate Specificity | Transcription Factors | Transcriptional Activation | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.